“The existing condition has exposed some structural weaknesses during the EU’s medicines provide chain in addition to a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides mentioned. She recommended that offer chain issues be tackled within an EU pharmaceutical tactic expected to get launched… Read More